|Andrea Cossarizza (born in 1958) took the degree in Medicine and Surgery at the University of Padua, then the PhD in Oncology at the University of Bologna and University of Modena, and the Specialization in Clinical Pathology and Immunohematology at the University of Modena and Reggio Emilia. As medical student he visited the Basel Institute of Immunology and then NYU. After some periods in different Institutes (Charing Cross Sunley Res. Ctr., London; Univ. Cochin, Paris; UCLA), in 1998 he became Associate Professor of General Pathology and Immunology at the University of Modena and Reggio Emilia, and in 2010 was appointed Full Professor. He authored 320 papers in peer reviewed international journals and gave >450 lectures. He is President of the International Society for Advancement of Cytometry, that counts thousands of members in 52 countries. His main scientific interests are aging and longevity, HIV infection, autoimmunity, mitochondria and cell death.|
|Mosepele Mosepele MD, MSc, is a Senior Lecturer & Acting Assistant Programme Director (Convener of Master of Medicine, Internal Medicine) at the University of Botswana Faculty of Medicine, is a Specialist Physician, Infectious Disease Consultant and Clinical Epidemiologist with experience in research focused on HIV-associated complications such as cardiovascular disease, immune dysregulation plus HIV treatment and care. His most current end-organ work has focussed on predicting risk factors for CVD (atherosclerotic versus non-atherosclerotic), neurocognitive impairment among virally suppressed HIV-infected patients, plus the role of gut dysbiosis in persistent inflammation despite viral suppression among HIV-infected patients in Botswana. His work on HIV treatment and care has focussed on (1) the link between HIV drug metabolism (including role of host single nucleotide polymorphism) and clinical outcomes, and (2) use of social network theory to identify HIV patient treatment partner (treatment buddy) characteristics that are associated with viral suppression, among others.|
|Matthias Blüher is Professor of Molecular Endocrinology and Speaker of the Collaborative Research Center “Obesity mechanisms” at the University of Leipzig in Leipzig, Germany. Matthias Blüher´s research is focused on the role of adipose tissue function and distribution in insulin resistance, the development of type 2 diabetes and other metabolic and cardiovascular diseases. Matthias´ work has been recognised both nationally and internationally, as he is a recipient of the Obesity Research Award of the German Obesity Society 2003, the Ferdinand-Bertram-Prize of the German Diabetes Association 2008, a European Association for the Study of Diabetes (EASD) Minkowski Award (2008), and the Minkowski Prize of the EASD 2015. Professor Blüher completed his medical studies at the University of Leipzig and his postdoctoral fellowship at the Joslin Diabetes Centre (C. R. Kahn), Harvard Medical School, Boston, USA.|
|Ronald Ma is Professor at the Department of Medicine and Therapeutics, Chinese University, Hong Kong and Honorary Consultant Physician, Division Head of Diabetes and Endocrinology, Prince of Wales Hospital, Hong Kong. He is a past president of Diabetes Hongkong, a charitable voluntary organization dedicated to promote social awareness of diabetes and to serve patients with diabetes.
Dr Ma completed his medical training at the University of Cambridge, UK and trained in Internal Medicine in London. He subsequently returned to Hong Kong, where he completed his endocrinology fellowship training. Through support from a Croucher Foundation Fellowship, he furthered his research interest in the area of diabetic complications at the Joslin Diabetes Center, Harvard Medical School, Boston, USA, under the mentorship of Professor George King.
Dr Ma’s research focuses on the epidemiology and genetics of diabetes and its complications, gestational diabetes, polycystic ovary syndrome, and the developmental origins of diabetes. Together with Prof Wing Hung Tam, he evaluated the metabolic outcome in mothers and offspring from the HAPO Hong Kong Field Centre, and is an investigator in the multi-centre HAPO Follow-up Study. He is currently leading a mutli-disciplinary project team to leverage on the large Hong Kong Diabetes Registry and accompanying biobank to identify novel molecular markers for GDM and diabetic complications, and is the principal investigator of the newly established Hong Kong Diabetes Biobank. He has published over 200 research articles in international peer-reviewed journals including Nature, Nature Genetics, Lancet, JAMA, Lancet Diabetes and Endocrinology and Diabetes, and authored 10 book chapters. Dr Ma is a recipient of several awards, including the Young Investigator Award from the International Diabetes Epidemiology Group (IDEG), Ten Outstanding Young Persons Award, Hong Kong (2009), the Albert Renold Fellowship from the European Association for the Study of Diabetes (2010), the Research Excellence Award (2011) and the Outstanding Fellowship of Faculty of Medicine from the Chinese University of Hong Kong (2014), and the Sir David Todd Lectureship from the Hong Kong College of Physicians (2015).
Dr Ma is the immediate Past President of the International Diabetes Epidemiology Group, and currently serves as the President of the Hong Kong Society of Endocrinology, Metabolism and Reproduction (HKSEMR), a member of the Executive Board, the Asian Association for the Study of Diabetes (AASD) and Council Member of the International Society for Developmental Origins of Health and Disease (DOHaD). He has recently served on the World Health Organization Working Group on Science and Evidence to End Childhood Obesity (ECHO), and as a member of the International Federation of Gynaecology and Obstetrics (FIGO) Committee on Pregnancy and NCD. He is an Associate Editor of Diabetic Medicine, and editorial board member of PLoS Medicine, Obesity Reviews, Nutrition, Metabolism and Cardiovascular Diseases, and Journal of Diabetes Investigation.
|Dr. Charles Rotimi, a genetic epidemiologist, is the Chief of the Metabolic, Cardiovascular and Inflammatory Disease Genomics Branch and the Director of the Center for Research on Genomics and Global Health at the US National Institutes of Health. Rotimi has directed innovative research to understanding the genomic, social and cultural determinants of metabolic diseases with attention to African ancestry populations. He a leader in exploring the implications of admixture and the increased genetic diversity in African ancestry populations for disease gene mapping. His research uncovers complex ways that ancestry can influence genetic findings. Rotimi is especially proud of his efforts at globalizing genomics. His engagement of African communities for the HapMap and 1000 Genomes projects has had a transformative impact. Rotimi was the founding president of the now thriving African Society of Human Genetics, and spearheaded formation of the H3Africa Initiative with over 170 million US dollars funding from the NIH and the Wellcome Trust. His work and achievements have been profiled in leading scientific journals and News Media including NEJM, Science, Nature, Lancet, Nature Medicine, New York Times, Newsweek Magazine, and British Broadcasting Corporation (BBC).|